Skip to main content

Find Clinical Trials

Home
Conditions
Chronic Hepatitis B

Clinical trial condition

Chronic Hepatitis B

Explore clinical trials studying Chronic Hepatitis B. Study availability and eligibility vary by location and protocol.

311 public trials 42 recruiting studies

Refine in advanced search Browse all conditions

Chronic Hepatitis B trial results

Completed

Safety and Efficacy Study of LB80380 in the Patients With Lamivudine-Refractory Chronic Hepatitis B

NCT00895596

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations: Queen Mary Hospital Hong Kong, China

Korea University Medical Center Seoul, South Korea

Severance Hospital of Yonsei University Seoul, South Korea

The Catholic University of Korea, Kangnam St. Mary's Hospital Seoul, South Korea

View Trial Details

Completed

A Efficacy and Safety Study of Adefovir Dipivoxil to Treat Chinese Patients With HBeAg+ve Chronic Hepatitis B

NCT00857675

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations: GSK Investigational Site Guangzhou, Guangdong, China

GSK Investigational Site Guangzhou, Guangdong, China

GSK Investigational Site Changchun, Jilin, China

GSK Investigational Site Jinan, Shandong, China

View Trial Details

Completed

Evaluation of Chronic HBV Patients w/Evidence of HBV Replication and Normal or Minimally Elevated Liver Transaminases.

NCT00263614

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations: Gilead Sciences, Inc. Foster City, California, United States

View Trial Details

Completed

Safety Study of HBV DNA Vaccine to Treat Patients With Chronic Hepatitis B Infection

NCT00277576

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations: Queen Mary Hospital Hong Kong

19/F Prince of Wales Hospital Shatin, Hong Kong

Alice Ho Miu Ling Nethersole Hospital Tai Po, N. T., Hong Kong

National University Hospital Singapore

View Trial Details

Completed

Different Regimens of Pegylated Interferon and Lamivudine Combination Therapy in Chronic Hepatitis B Patients

NCT00226447

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations: Cheng Suen Man Shook Hepatitis Center, Institute of Digestive Disease, The Chinese University of Hong Kong, Prince of Wales Hospital Hong Kong SAR, China

View Trial Details

Completed

Lamivudine Plus Interferon Versus Lamivudine For The Treatment Of HBeAg Positive Chronic Hepatitis B Virus (HBV)

NCT00140725

Conditions: Blood-Borne Infections, Bronchial Diseases, Bronchiolitis, +36 more
Locations: GSK Investigational Site Shatin, Hong Kong

View Trial Details

Completed

Lamivudine and Adefovir to Treat Chronic Hepatitis B Infection in People With and Without HIV Infection

NCT00023153

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +25 more
Locations: National Institute of Allergy and Infectious Diseases (NIAID) Bethesda, Maryland, United States

View Trial Details

Completed

Lamivudine for Chronic Hepatitis B

NCT00001457

Conditions: Arteritis, Blood-Borne Infections, Cardiovascular Diseases, +37 more
Locations: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Bethesda, Maryland, United States

View Trial Details

Completed

Long Term Follow-up of Pegylated-Interferon Alpha-2b

NCT00146705

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations: University Medical Center Rotterdam Rotterdam, Dr Molewaterplein 40, Netherlands

View Trial Details

Completed

Trial of Lamivudine Treatment in HBeAg Negative Chronic Hepatitis B Patients (in Asia)

NCT00338780

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations: Cheng Suen Man Shook Hepatitis Center, Institute of Digestive Disease, The Chinese University of Hong Kong, Prince of Wales Hospital Hong Kong SAR, China

View Trial Details